Bill journey · stage 1 of 5
Just introduced
What it doesSummary passed senate (Dec 15, 2020)
Cannabidiol and Marihuana Research Expansion Act
This bill modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.
What just happenedDec 16, 2020
Held at the desk.
Who’s behind it
Held at the desk.
Received in the House.
Message on Senate action sent to the House.
Passed Senate with an amendment by Voice Vote. (text of amendment in the nature of a substitute: CR S7504-7507)
Passed/agreed to in Senate: Passed Senate with an amendment by Voice Vote.(text of amendment in the nature of a substitute: CR S7504-7507)
Measure laid before Senate by unanimous consent. (consideration: CR S7508)
Senate Committee on the Judiciary discharged by Unanimous Consent.
Senate Committee on the Judiciary discharged by Unanimous Consent.
Committee on United States Senate Caucus on International Narcotics Control. Hearings held.
Read twice and referred to the Committee on the Judiciary. (Sponsor introductory remarks on measure: CR S4633-4634)
Introduced in Senate
Cannabidiol and Marihuana Research Expansion Act
This bill modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.
Cannabidiol and Marihuana Research Expansion Act
This bill modifies provisions concerning the federal regulation of certain drugs that are deemed to pose a risk of abuse and dependence to facilitate research on, and the use of, medical treatments containing marijuana and its derivatives.